-
Huaweiâs strategic planning head Emil Zhang on upping pool participation in âcriticalâ verticals
Read more: Huaweiâs strategic planning head Emil Zhang on upping pool participation in âcriticalâ verticalsHuawei believes patent pools, such as Sisvelâs point-of-sale patent programme, will fix all the legal uncertainty in critical, fragmented technology verticals, the companyâs Head of Strategic Planning & Key Projects Department told ip fray in an exclusive interview.
-
UPC Roundup (1 week): CoA grants Abbott PI after Hague denial, clarifies technicity analysis; various other decisions
Read more: UPC Roundup (1 week): CoA grants Abbott PI after Hague denial, clarifies technicity analysis; various other decisionsThis is a summary of developments in and around the Unified Patent Court (UPC) in the calendar week of April 13, 2026. It is one of our longest UPC Roundups to date. 11. Around the court 11.1 Brazil court cites UPC ruling, referencing ip fray, in Panasonic v. HMD PI decision (link to detailed article)…
-
ACTâs desire to cooperate with ETSI tests limits of FRAND policy compatibility
Read more: ACTâs desire to cooperate with ETSI tests limits of FRAND policy compatibilityACTâs planned cooperation with ETSI is putting its IPR policy compatibility standard to the test. A FRAND framework limited to specific activities may meet functional requirements, but raises questions about consistency, predictability, and the boundaries of ETSIâs approach.
-
Brazilian court enters Panasonic v. HMD PI: Via AAC pool offer was FRAND enough; UPC, German case law cited; ruling points to ip fray
Read more: Brazilian court enters Panasonic v. HMD PI: Via AAC pool offer was FRAND enough; UPC, German case law cited; ruling points to ip frayBrazilian SEP case law is evolving rapidly, and the judges in Rio de Janeiro increasingly follow developments in other jurisdictions. Occasionally they do so via ip fray.
-
Federal Circuit revives Teva’s $177M (potentially $530M) damages verdict against Eli Lilly over Emgality headache drug
Read more: Federal Circuit revives Teva’s $177M (potentially $530M) damages verdict against Eli Lilly over Emgality headache drugA $177M jury verdict, potentially tripled for willfulness, has been reinstated, and the standards for written description and enablement for genus-related patents have been clarified.
-
Corning wins UPC injunction against TCL TVs over glass sheet patent, validating Hisense decision to settle just before CD ruling on validity
Read more: Corning wins UPC injunction against TCL TVs over glass sheet patent, validating Hisense decision to settle just before CD ruling on validityAfter getting LG and Hisense to settle, Corning has now won a UPC ruling against TCL over glass sheets used in TVs. The patent will expire in June, however, and TCL says its current products do not infringe.
-
For indirect infringement, the other component need not actually exist, says UPC Dusseldorf LD in filter cartridge case
Read more: For indirect infringement, the other component need not actually exist, says UPC Dusseldorf LD in filter cartridge caseThe UPC’s Dusseldorf LD ruled that a filter cartridge can indirectly infringe a patent even if the complementary funnel is not yet on the market. It also clarified patent exhaustion.
Follow Us
Latest Articles
- Podcast: interview with Dr. Peter Georg Picht, SEP and competition law expert
- Geely takes Avanci license: combination of three near-simultaneous events leaves no room for reasonable doubt
- Compliance statement on Licensing Executives Society’s alleged Chatham House rule at UPC +3 YEARS event: here’s the evidence
- BREAKING: Nokia and Geely settled cellular SEP dispute; unknown if pool or bilateral license
- Samsung leads U.S. AI patent grants 2025, otherwise largely dominated by Big TechÂ